Salvage treatment for recurrent oropharyngeal squamous cell carcinoma

Head and Neck

Volumn 32, Issue 8, 2010, Pages 989-996

  Röösli, Christof ^a   Studer, Gabriela ^a   Stoeckli, Sandro J ^a,b  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b Clinic of Otorhinolaryngology   (Switzerland)

Author keywords

Head and neck; Oropharynx; Radiotherapy; Recurrence; Salvage surgery

Indexed keywords

ADULT; ADVANCED CANCER; AGED; ARTICLE; BLEEDING; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CERVICAL LYMPH NODE; COHORT ANALYSIS; FEMALE; FOLLOW UP; HUMAN; LYMPHEDEMA; MAJOR CLINICAL STUDY; MALE; NECK DISSECTION; OROPHARYNX CARCINOMA; OVERALL SURVIVAL; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RECURRENT CANCER; SALVAGE THERAPY; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; COHORT STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; OROPHARYNGEAL NEOPLASMS; RETROSPECTIVE STUDIES; SALVAGE THERAPY; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 77955602982     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.21273     Document Type: Article

References (34)

1. Hoffman HT, Karnell LH, Funk GF, Robinson RA, Menck HR. The National Cancer Data Base report on cancer of the head and neck. Arch Otolaryngol Head Neck Surg 1998;124:951-962. (Pubitemid 28411496)
2. Swiss Association of Cancer Registries. August 24, 2006. Available at: http://www.asrt.ch/asrt/newstat/extracted-from-globocan2002.pdf
3. D'souza G, Kreimer AR, Viscidi R, et al. Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med 2007;356:1944-1956.
4. Hammarstedt L, Lindquist D, Dahlstrand H, et al. Human papillomavirus as a risk factor for the increase in incidence of tonsillar cancer. Int J Cancer 2006;119: 2620-2623.
5. Perrone F, Mariani L, Pastore E, et al. p53 codon 72 polymorphisms in human papillomavirus-negative and human papillomavirus-positive squamous cell carcinomas of the oropharynx. Cancer 2007;109:2461-2465.
6. Hicks WL Jr, Kuriakose MA, Loree TR, et al. Surgery versus radiation therapy as single-modality treatment of tonsillar fossa carcinoma: the Roswell Park Cancer Institute experience (1971-1991). Laryngoscope 1998;108: 1014-1019.
7. Perez CA, Patel MM, Chao KS, et al. Carcinoma of the tonsillar fossa: prognostic factors and long-term therapy outcome. Int J Radiat Oncol Biol Phys 1998;42:1077-1084.
8. Johansen LV, Grau C, Overgaard J. Squamous cell carcinoma of the oropharynx: an analysis of treatment results in 289 consecutive patients. Acta Oncol 2000;39:985-994.
9. Lanza L, Rizzi L, Durso D, Occhini A, Benazzo M, Tinelli C. Integrated treatment in locally advanced carcinoma of the oropharynx. J Surg Oncol 2000;74:75-78.
10. Zelefsky MJ, Harrison LB, Fass DE, Armstrong JG, Shah JP, Strong EW. Postoperative radiation therapy for squamous cell carcinomas of the oral cavity and oropharynx: impact of therapy on patients with positive surgical margins. Int J Radiat Oncol Biol Phys 1993;25:17-21.
11. Steiner W, Vogt P, Ambrosch P, Kron M. Transoral carbon dioxide laser microsurgery for recurrent glottic carcinoma after radiotherapy. Head Neck 2004;26:477-484.
12. Forastiere AA, Goepfert H, Maor M, et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 2003;349: 2091-2098.
13. Carvalho AL, Magrin J, Kowalski LP. Sites of recurrence in oral and oropharyngeal cancers according to the treatment approach. Oral Dis 2003;9:112-118.
14. Goodwin W Jr. Salvage surgery for patients with recurrent squamous cell carcinoma of the upper aerodigestive tract: when do the ends justify the means. Laryngoscope 2000;110(Suppl 93):1-18.
15. Röösli C, Tschudi DC, Studer G, Braun J, Stoeckli SJ. Outcome of patients after treatment for a squamous cell carinoma of the oropharynx. Laryngoscope 2009;119: 534-540.
16. Wittekind C, Compton CC, Greene FL, Sobin LH. TNM residual tumour classification revisited. Cancer 2002;94: 2511-2516.
17. Studer G, Huguenin PU, Davis JB, Kunz G, Lütolf UM, Glanzmann C. IMRT using simultaneously integrated boost (SIB) in head and neck cancer patients. Radiat Oncol 2006;1:7 (abstract).
18. Bernier J, Domenge C, Ozsahin M, et al. European Organization for Research and Treatment of Cancer Trial 22931. Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med 2004;350:1945-1952.
19. Huguenin P, Beer KT, Allal A, et al. Concomitant cisplatin significantly improves locoregional control in advanced head and neck cancers treated with hyperfractionated radiotherapy. J Clin Oncol 2004;22: 4665-4673.
20. Tschudi D, Stoeckli S, Schmid S. Quality of life after different treatment modalities for carcinoma of the oropharynx. Laryngoscope 2003;113:1949-1954.
21. Agra IM, Carvalho AL, Ulbrich FS, et al. Prognostic factors in salvage surgery for recurrent oral and oropharyngeal cancer. Head Neck 2006;28:107-113.
22. Grant DG, Salassa JR, Hinni ML, Pearson BW, Hayden RE, Perry WC. Transoral laser microsurgery for recurrent laryngeal and pharyngeal cancer. Otolaryngol Head Neck Surg 2008;138:606-613.
23. Wong LY, Vei WI, Lam LK, Yuen AP. Salvage of recurrent head and neck squamous cell carcinoma after primary curative surgery. Head Neck 2003;25:953-959.
24. Gilbert H, Kagan AR. Recurrence patterns in squamous cell carcinoma of the oral cavity, pharynx, larynx. J Surg Oncol 1974;5:357-380.
25. Gehanno P, Depaudt J, Guedon C, Kebaili C, Koka V. Primary and salvage surgery for cancer of the tonsillar region: a retrospective study of 120 patients. Head Neck 1993;15:185-189.
26. Schwartz GJ, Mehta RH, Wenig BL, Shaligram C, Portugal LG. Salvage treatment for recurrent squamous cell carcinoma of the oral cavity. Head Neck 2000;22:34-41.
27. Temam S, Pape E, Janot F, et al. Salvage surgery after failure of very accelerated radiotherapy in advanced head-and-neck squamous cell carcinoma. Int J Radiation Oncol Biol Phys 2005;62:1078-1083. (Pubitemid 40884420)
28. Gleich LL, Ryzenmann J, Gluckman JL, Wilson KM, Barrett WL, Redmond KP. Recurrent advanced (T3 or T4) head and neck squamous cell carcinoma: Is salvage possible? Arch Otolaryngol Head Neck Surg 2004;130: 35-38.
29. Yuen APW, Wei WI, Lam LK, Ho WK, Kwong D. Results of surgical salvage of locoregional recurrence of carcinoma of the tongue after radiotherapy failure. Ann Otol Rhinol Laryngol 1997;106:779-782.
30. Buck G, Huguenin P, Stoeckli SJ. Efficacy of neck treatment in patients with head and neck squamous cell carcinoma. Head Neck 2008;30:50-57.
31. Pacheco-Ojeda L, Marandas P, Julieron M, Lusinchi A, Mamelle G, Luboinski B. Salvage surgery by composite resection for epidermoid carcinoma of the tonsillar region. Arch Otolaryngol Head Neck Surg 1992;118:181-184.
32. Rodriguez J, Point D, Bruhin F, Jaulerry C, Brugère J. Surgery of oropharynx after radiotherapy. Bull Cancer Radiother 1996;83:24-30.
33. Cooney TR, Poulsen MG. Is routine follow-up useful after combined-modality therapy for advanced head and neck cancer? Arch Otolaryngol Head Neck Surg 1999; 125:379-382.
34. Chedid HM, Franzi SA. Assessment of demographics factors and clinical staging in patients submitted to salvage surgery for oropharyngeal squamous cell carcinoma. Rev Bras Otorrinolaringol 2008;74:532-536.